news aktuell GmbH

Grünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officer

Share
Grünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officer (CSO).
Grünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officer (CSO).

Aachen, Germany, 09 January 2025 – Grünenthal announced today that Prof. Dr. Uli Brödl will assume the role of Chief Scientific Officer (CSO) and Member of the Corporate Executive Board, effective 01 February 2025.

Uli Brödl has more than 15 years of industry experience. He joins Grünenthal from Boehringer Ingelheim, where he served as Corporate Senior Vice President, Head of Global Clinical Development & Operations, and member of Boehringer Ingelheim's Venture Fund Investment Committee. In his most recent role, he oversaw end-to-end clinical development and operations activities across therapeutic areas and worked at the interface of R&D, Commercial, and Market Access functions. He has a proven track record of bringing innovative medicines to patients, including Empagliflozin, an oral anti-diabetic medicine. Earlier in his career, Uli Brödl led Boehringer Ingelheim's Canadian medical organisation and gained extensive market experience. In parallel, he founded and co-chaired the BI Canada Incubator, an innovation lab to develop innovative healthcare solutions.

Uli Brödl graduated as a Medical Doctor from Ludwig-Maximilians University Munich. He is a board-certified internist and endocrinologist and an Adjunct Professor of Internal Medicine at the Ludwig-Maximilians University Munich.

"The unique focus on improving the quality of life of underserved patients suffering from pain attracted me to Grünenthal,” says Uli Brödl. "I look forward to joining the team and further driving Grünenthal’s innovation pipeline."

"With Uli, we have been able to attract an excellent leader," says Gabriel Baertschi, CEO of Grünenthal. "His extensive experience in R&D and commercial functions combined with Uli's drive to bring innovative medicines to patients will help us propel our vision of a world free of pain."

About Grünenthal

Grünenthal is a global leader in pain management and related diseases. As a science-based, fully integrated pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. Our purpose is to change lives for the better – and innovation is our passion. We focus all our activities and efforts on working towards our vision of a World Free of Pain.

Grünenthal is headquartered in Aachen, Germany, and has affiliates in 27 countries across Europe, Latin America, and the U.S. Our products are available in approx. 100 countries. In 2023, Grünenthal employed around 4,400 people and achieved revenues of €1.8 billion.

More information: https://www.grunenthal.com

Follow us on:

LinkedIn: Grunenthal Group

Instagram: grunenthal

 

For further information, please contact:

Florian Dieckmann, Head Global Corporate Affairs & Communication

Tel.: +49 241 569-2555

Florian.Dieckmann@grunenthal.com

Images

Grünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officer (CSO).
Grünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officer (CSO).
Download

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

Australia’s next government must mend structural cracks appearing in its political, economic and social foundation, report finds25.4.2025 12:05:00 CEST | Pressmeddelande

- Picture is available at AP - Los Angeles/DNA - Australia boasts some of the world’s most sophisticated political institutions and one of its wealthiest economies. But this veneer of success masks deeper structural issues — and a “ticking time bomb” of overreliance on extractive industries must be addressed under Australia’s next government, a new report recommends.

DYMO® LETRATAG 200B VINNER DET PRESTIGEFYLLDA PRISET ”BUSINESS PRODUCT OF THE YEAR” - STRUKTURERAR OCH ORGANISERAR VARDAGEN24.4.2025 16:44:06 CEST | Press Release

Amsterdam – vikten av organisering, effektivitet och produktivitet i både personliga och professionella sammanhang har aldrig varit större. Detta då allt fler använder smarta lösningar för att förenkla sin vardag. DYMO®, en ledande leverantör av innovativa etikett- och utskriftslösningar, ligger här i framkant. Som ett erkännande har DYMO LetraTag 200B belönats med EOPA Best Business Product Award, en utmärkelse som lyfter fram hur den förenklat organisering både hemma och på kontoret. "Trenden mot smart självorganisering fortsätter", berättar Liesbet De Soomer, Global Marketing Director på DYMO. "LetraTag 200B stödjer utveckligen genom att erbjuda en användarvänlig lösning, som gör märkningen snabb och enkel. Med det här verktyget kan användaren strukturera vardagskaoset och organisera tillvaron.” EOPA Best Business Product Award, som delas ut årligen, uppmärksammar produkter som sticker ut för sitt nytänkande, sin funktionalitet och sin användarvänlighet. LetraTag 200B:s utmärkelse b

Canada must reduce reliance on extractive industries and U.S. exports, report finds22.4.2025 08:34:18 CEST | Press Release

Los Angeles/Ottawa (DNA) - From dissatisfaction with the Trudeau government to dissatisfaction with Trump’s policies — compounded by general anxiety around tariffs, the economy and a deteriorating relationship with the U.S. — navigating an economic downturn should be an immediate priority for Canada as it heads into a federal election, a new report recommends. In the long-term, however, it says Canada will need greater economic diversification and regional representation. “Although it is wealthy by global standards, Canada’s economy faces key vulnerabilities such as excessive reliance on extractive industries, shortages of critical goods like housing and heavy dependence on exports to the U.S.,” states a Canada BGI Report on the country’s governance performance, released a little more than ten days before the April 28 federal election. The report, based on the Berggruen Governance Index (BGI), was conducted by researchers from the Los Angeles-based Berggruen Institute think tank, the L

“Relaxing rocks”: Spectacular naming of Mein Schiff Relax with Robbie Williams10.4.2025 16:41:15 CEST | Press Release

For the first time, guests of three ships in the fleet were able to experience the festive moment together The staging of the naming ceremony, a choir and many technical refinements such as lasers, video mapping and LED wristbands ensured “endless moments” International superstar and feel-good ambassador of Mein Schiff Relax Robbie Williams wows over 12,000 people with his concert Three ships and a naming ceremony: unique and unprecedented fleet get-together – Mein Schiff 5, Mein Schiff 7 and Mein Schiff Relax in the port of Málaga

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye